Physician profile
Michael C Carroll
NPI 1427051291
$6,829.98
in general payments reported to CMS, 2019-2025
38 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $449 · 2021: $620 · 2022: $809 · 2023: $1,505 · 2024: $863 · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,715 · Travel and Lodging: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,715.45 |
| Travel and Lodging | $683.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,053.97 | 2019-2024 | Apex 3d, Silverback |
| Organogenesis INC. | $771.01 | 2020-2025 | Puraply, Puraforce, Apligraf |
| Treace Medical Concepts, INC. | $568.49 | 2022-2024 | |
| Stryker Corporation | $526.22 | 2020-2025 | Easyfuse, Augment Injectable, Dart-Fire |
| Ani Pharmaceuticals, INC. | $346.32 | 2023-2025 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $282.65 | 2020-2025 | Nuzyra |
| Medtronic, INC. | $248.65 | 2022-2025 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $213.56 | 2020-2025 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Horizon Therapeutics Plc | $179.91 | 2019-2023 | Krystexxa |
| Kerecis Limited | $175.35 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $168.28 | 2024-2025 | |
| Arthrosurface Incorporated | $154.55 | 2019-2020 | |
| Depuy Synthes Sales INC. | $129.89 | 2020-2025 | Motoband |
| Medline Industries LP | $122.53 | 2019 | |
| Orthofix Medical, INC. | $95.03 | 2022-2025 | Physio-Stim |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $91.76 | 2024-2025 | Krystexxa |
| Dynasplint Systems INC. | $73.81 | 2020-2025 | Dynasplint |
| Bioventus LLC | $62.58 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $61.93 | 2021-2022 | |
| Djo, LLC | $59.28 | 2019-2023 | Donjoy |
| Merck Sharp & Dohme LLC | $48.14 | 2019 | |
| Integra Lifesciences Corporation | $46.33 | 2020-2021 | |
| Urgo Medical North America, LLC | $42.66 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Solventum Corporation | $34.69 | 2024 | V.A.C.Ulta |
| Heron Therapeutics, INC. | $30.04 | 2021-2022 | |
| Tactile Systems Technology INC | $28.40 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $28.15 | 2025 | |
| Zimmer Biomet Holdings, INC. | $23.65 | 2020 | |
| Medela LLC | $21.49 | 2020 | |
| Nabriva Therapeutics, Plc | $21.42 | 2021 | |
| Reprise Biomedical, INC. | $19.88 | 2025 | Miro 3d |
| Globus Medical, INC. | $18.12 | 2025 | Senza |
| Biocomposites INC | $14.95 | 2025 | Stimulan |
| Ibsa Pharma INC. | $14.82 | 2023 | Tirosint, Licart |
| Pacira Pharmaceuticals Incorporated | $13.94 | 2019 | |
| Nevro Corp. | $13.83 | 2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $12.71 | 2023 | Seglentis |
| Cardiovascular Systems INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,195,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.